RECENT DEVELOPMENTS IN DOSAGE FORM DESIGN

被引:2
作者
DAVIS, SS [1 ]
机构
[1] UNIV NOTTINGHAM,DEPT PHARM,NOTTINGHAM NG7 2RD,ENGLAND
来源
DRUG DEVELOPMENT COMMUNICATIONS | 1976年 / 2卷 / 02期
关键词
D O I
10.3109/03639047609051900
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:151 / 169
页数:19
相关论文
共 12 条
[1]  
ARIENS EJ, 1973, DRUG DESIGN, V4, pR11
[2]   STRATEGY IN DRUG DESIGN - CLUSTER ANALYSIS AS AN AID IN SELECTION OF SUBSTITUENTS [J].
HANSCH, C ;
UNGER, SH ;
FORSYTHE, AB .
JOURNAL OF MEDICINAL CHEMISTRY, 1973, 16 (11) :1217-1222
[3]  
Hansch C., 1971, DRUG DESIGN, V11, P271
[4]  
JONES A, 1975, BRIT J CLIN PRACT, V29, P268
[5]  
KAPLAN SA, 1973, DOSAGE FORM DESIGN B, P1
[6]  
KNUDSEN ET, 1975, BRIT J CLIN PRACT, V29, P255
[7]   QUANTITATIVE DRUG DESIGN [J].
REDL, G ;
CRAMER, RD ;
BERKOFF, CE .
CHEMICAL SOCIETY REVIEWS, 1974, 3 (03) :273-292
[8]  
SHELL JW, 1974, ANN OPHTHALMOL, V6, P1037
[9]   RATIONALE FOR DESIGN OF BIOLOGICALLY REVERSIBLE DRUG DERIVATIVES - PRODRUGS [J].
SINKULA, AA ;
YALKOWSKY, SH .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1975, 64 (02) :181-210
[10]  
SPAETH GL, 1970, INVEST OPHTH VISUAL, V9, P73